Journals / Turkish Neurosurgery / 2014 / Cilt: 24 - Sayı: 1

Anevrizmal Subaraknoid Hemorajide Yeni Bir Molekül: Dendroaspis Natriüretik Peptid

A New Molecule in Aneurysmal Subarachnoid hemorrhage: Dendroaspis Natriuretic peptide

Pages
38–43
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The findings of present study are believed to encourage further studies regarding receptors and receptor specific drugs

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIm: Dendroaspis natriuretic peptide (DNP) is the most recently identified member of the natriuretic peptide family.
📊
Key Findings & Data:In this study, we aimed to find out the role of DNP in the development of vasospasm following aneurysmal SAH (subarachnoid hemorrhage). mAterIAl and methOds: DNP levels of 17 patients diagnosed with aneurysmal SAH and 25 volunteers as control were measured.
💡
Conclusion & Impact:The findings of present study are believed to encourage further studies regarding receptors and receptor specific drugs
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIm: Dendroaspis natriuretic peptide (DNP) is the most recently identified member of the natriuretic peptide family. Although DNP has similar structure and function to other members, it is genetically different. The other members are known to cause vasorelaxation but the effects of DNP on vascular structure still remains unclear. In this study, we aimed to find out the role of DNP in the development of vasospasm following aneurysmal SAH (subarachnoid hemorrhage). mAterIAl and methOds: DNP levels of 17 patients diagnosed with aneurysmal SAH and 25 volunteers as control were measured. All SAH patients were treated with aneurysm clip. Five ml of venous blood sample was obtained on postoperative 1, 3 and 7th days from each patient. Additionally, DNP levels were determined by obtaining cerebrospinal fluid (CSF) postoperative 1, 3 and 7th days. results: Statistically significant difference was observed between cerebrospinal fluid DNP levels on day 1 and day 3 (P<0.05). COnClusIOn: This study suggests that DNP can be anticipated among molecules leading development of vasospasm. The findings of present study are believed to encourage further studies regarding receptors and receptor specific drugs

Özet

AmAÇ: Dendroaspis natriüretik peptid (DNP), natriüretik peptid ailesinin en yeni üyesidir. Yapısal olarak diğer üyelerine benzemesine rağmen genetik olarak farklıdır. Diğer üyelerin vazorelaksasyona neden olduğu bilinmesine rağmen DNP nin insanın vasküler yapısındaki etkisi bilinmemektedir. Bu çalışmada Anevrizmal SAH (subaraknoid hemoraji) sonrası vazospazm gelişiminde DNP nin rolunü araştırdık.yÖntem ve GereÇler: Anevrizmal SAH tanısı konan 17 hasta ve 25 gönüllü kontrol grubunda DNP düzeyleri araştırıldı. Tüm SAH hastaları anevrizma klibi ile tedavi edildi. Postoperatif dönemde 5ml venöz kan 1., 3., 7. günlerde alındı. 1., 3., 7. günlerde Beyin Omurilik Sıvısı (BOS) alınarak DNP düzeyleri incelendi. BulGulAr: Olguların 1.gün BOS'taki DNP düzeyleri 3.gündeki DNP düzeylerinden anlamlı derecede yüksektir (P<0,05). sOnuÇ: Bu çalışma, DNP'nin vazospazm gelişmesinde etkenlerden biri olabileceğini düşündürmektedir. Çalışmamızın gelecekte reseptör düzeyinde yapılacak çalışmalar ve bu reseptörlere özgü yeni ilaç çalışmalarını cesaretlendireceğine inanmaktayız

🔖

Cite This Article

SEREFHAN, A., ALTAŞ, M., ÇERÇİ, A., IŞIK, N., ELMACI, İ. (2014). Anevrizmal Subaraknoid Hemorajide Yeni Bir Molekül: Dendroaspis Natriüretik Peptid. Turkish Neurosurgery, Cilt: 24 - Sayı: 1, 38–43. https://ajindex.com/articles/404870

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, et al: Perindopril-based blood pressure-lowering therapy reduces amino-terminalpro- B-type natriuretic peptide in individuals with cerebrovascular disease. J Hypertens 25:699-705, 2007 2. Chen HH, Burnett JC: Natriuretic peptides in pathophysiology of congestive heart failure. Curr Cardiol Rep 2:198-205, 2000 3. Collins E, Bracamonte MP, Burnett JC jr, Miller WM: Mechanism of relaxations of Dendroaspis natriuretic peptide in canine coronary arteries. J Cardiovasc Pharmacol 35: 614-618, 2000 4. Dorsch NWC, King MT: A review of cerebral vasospasm in aneursymal subarachnoid hemorrhage. Part I: Incidence and effects. J Clin Neurosci 1:19-26, 1994 5. Hasan D, Wijdicks EF, Vermeulen M: Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 27:106-108, 1990 6. Juul R, Edvinsson L, Ekman R, Frederiksen TA, Unsgard G, Gisvold SE: Atrial natriuretic peptide-L1 following subarachnoid hemorrhage in man. Acta Neurochir (Wien) 106:18-23, 1990 7. Khurana VG, Wijdicks EF, Heubline DM, McClellnd RL, Meyer FB, Piepgras DG, et al: A pilot study of Dendroaspis natriuretic peptide in aneursymal subarachnoid hemorrhage. Neurosurgery 55:69-76, 2004 8. Lee S, Park SK, Kang KP, Kang SK, Kim SZ, Kim W: Relationship of plasma dendroaspis natriuretic peptide-like immunoreactivity and echocardiographic parameters in chronic haemodialysis patients. Nephrology (Carlton) 9: 171-175, 2004 9. Lisy O, Lainchburry JG, Leskinen H, Burnett JC Jr: Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, Dendroaspis natriuretic peptide, in experimental severe congestive heart failure. Hypertension 37:1089-1094, 2001 10. McGirt MJ, Blessing R, Nimjee SM, Friedmann AH, Alexander MJ, Laskowitz DT, et al: Correlationof serum brain natriuretic peptide with hyponatremia and delayed ischemic neurologi-cal deficits after subarachnoid hemorrhage. Neurosurgery 54:1369-1373, 2004 11. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr: Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 40:976-982, 2002 12. Schweitz H, Vigne P, Moinier D, Frelin C, Lazdunski M: A new member of the natriuretic peptide family is present in the venom of the green mamba. J Biol Chem 267:13928-13932, 1992 13. Singh G, Maguire JJ, Kuc RE, Skepper JN, Fidock M, Davenport AP: Characterization of the snake venom ligand [12